Blog

Development of LC/MS for Regulated Bioanalysis

Development of LC/MS for Regulated Bioanalysis

2021-11-17

The rapid development of Liquid Chromatography/Mass Spectrometry (LC/MS) technology changed the way bioanalysis was done. Regulated Bioanalysis services are valuable to both the clinical and preclinical phases of studies.





Get a feel for our events

PSUR and RMP - Benefit Risk Masterclass with workshop - US edition

PSUR and RMP - Benefit Risk Masterclass with workshop - US edition

21-23 January, 2025

A comprehensive overlook on benefit risk assessment in PSUR and RMP

PSUR and RMP - Benefit Risk Masterclass with workshop - EU edition

PSUR and RMP - Benefit Risk Masterclass with workshop - EU edition

21-23 January, 2025

Connection between risk management with PBRERs and benefit-risk assessment and tools

check all pharma events